{
    "2018-03-01": [
        [
            {
                "time": "2018-03-01",
                "original_text": "今日资金抢入六只强势股一览（3月1日）-第3页",
                "features": {
                    "keywords": [
                        "资金流入",
                        "强势股",
                        "华兰生物"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "华兰生物股票行情：增速探底回升 温和渐进的恢复可期",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "增速回升",
                        "恢复可期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "华兰生物2017年总营收23.7亿 较上年同期增加22.41%",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "营收增长",
                        "2017年报"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "002007华兰生物|四季度销售环比继续改善，行业底部、静待变化",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "销售改善",
                        "行业底部"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "晨会聚焦180301：重点关注美亚柏科、广联达、石基信息、天虹股份、乐普医疗、扬杰科技",
                "features": {
                    "keywords": [
                        "晨会聚焦",
                        "重点推荐",
                        "乐普医疗",
                        "扬杰科技"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技",
                        "零售"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "[买入评级]华兰生物(002007)点评：Q4单季营收端有所恢复 静待利润端的改善",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "Q4营收恢复",
                        "利润改善"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}